Columbia Laboratories to Discuss Third Quarter 2014 Financial Results on October 28th Conference Call
BOSTON, Oct. 14, 2014 /PRNewswire/ -- The management team at Columbia Laboratories, Inc. (Nasdaq: CBRX) will hold a conference call on October 28th, 2014, to discuss financial results for the third quarter ended September 30, 2014. The call details are as follows:
| Date: |
Tuesday, October 28, 2014 |
| Time: |
8:30 AM EDT |
| Dial-in numbers: |
Toll free: (866) 374-4635 (U.S.), (855) 669-9657 (Canada) or, |
| International: (412) 902-4218 |
|
| Webcast (live & archive): |
www.columbialabs.com, under 'Investor' or click here |
The teleconference replay will be available approximately one hour after completion through Wednesday, November 5, 2014, at (877) 344-7529 (U.S.), (855) 669-9658 (Canada) or (412) 317-0088 (International). The conference ID for the replay is 10054330. The archived webcast will be available for one year via the aforementioned URLs.
About Columbia Laboratories
Columbia Laboratories, Inc. is a pharmaceutical development company providing formulation development, clinical trial manufacturing, and advanced analytical and consulting services to the pharmaceutical industry. The Company is also leveraging a successful heritage in developing women's health products and is advancing a proprietary product pipeline. Its most successful product to date, CRINONE® 8% (progesterone gel), is marketed by Actavis, Inc. in the U.S. and by Merck Serono S.A. in over 60 additional countries worldwide. For more information, please visit www.columbialabs.com.
CRINONE® is a registered trademark of Actavis, Inc. in the U.S.
Contact:
MBS Value Partners
Katja Buhrer
+212 661 7004
[email protected]
SOURCE Columbia Laboratories, Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article